Project Grant DP2LM014811

Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $1.3M
Federal Grant Program
93.879
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
The federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,507,500 to the University of Massachusetts Medical School (UMass Medical) to expand the capabilities of third-generation DNA/RNA sequencing technologies. The project aims to generate rapid and cost-effective training libraries to allow for direct detection of common DNA damage and RNA modifications, enabling innovative...
This $320,861 federal Project Grant awarded by the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences under CFDA 47.074 Biological Sciences supports research to develop tools for reading expanded genetic alphabets containing bases beyond A, T, G, and C. The project aims to improve the accuracy and generalizability of next-generation DNA sequencing for these unnatural base pairs through deep learning. It also develops new methods to measure polymerase replication...
This Project Grant award from the National Institute of Environmental Health Sciences under the Medical Library Assistance (CFDA 93.879) program provides $997,678 to the University of Wisconsin - Madison to develop automated methods for standardizing and enhancing the metadata in large biomedical databases such as the Sequence Read Archive and Gene Expression Omnibus. The goal is to improve the integration and querying of these public datasets to enable more powerful machine learning and...
This $131,085 Project Grant awarded by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will support research to develop and apply genomic large language models (LLMs) to advance understanding of the connections between genetic variants and radiomics phenotypes. The key products and services to be delivered under this 2-year award include: Developing new genomic LLM techniques to model how transcription factors bind to DNA and regulate gene expression in a...
This federal Project Grant award of $350,000 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a neural network-accelerated DNA and RNA sequence processing node, called CLEDGESEQ, for use in field, clinical, and industrial settings. The project aims to create advanced sequence analysis and communication capabilities for edge applications, enabling cost-effective and scalable DNA/RNA...
This $1,273,296 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to develop advanced models for predicting the impact of genetic variants on mRNA stability, translation, and protein levels. The key products and services to be delivered include: High-throughput reporter assays to characterize how variants in coding and untranslated regions impact mRNA stability and translation, including across multiple cell types....
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will provide $1,341,011.00 to the University of Pittsburgh to develop a novel computational framework integrating deep learning and causal discovery algorithms. The goal is to unveil the individualized (or instance-specific) cell-cell communication networks underlying tissue environment heterogeneity. This framework will enable the investigation of diverse cell-cell communication...
This $1,220,400 Project Grant awarded by the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences supports a collaborative research project between investigators in the U.S. and U.K. to better understand the regulatory mechanisms controlling mammalian gene expression. The project, funded through NSF's Biological Sciences program (CFDA 47.074), aims to define the roles of different DNA regulatory elements and how they work together to precisely control gene expression....
The National Human Genome Research Institute (NHGRI) awarded a $594,501 Project Grant (CFDA 93.172 - Human Genome Research) to Cold Spring Harbor Laboratory to develop a unified probabilistic model and software implementation for analyzing nascent RNA sequencing data. The project aims to create powerful computational tools that can accelerate transcriptional research by enabling the estimation of transcriptional rates directly from nascent RNA sequencing data, with applications in areas such...
The National Human Genome Research Institute (NHGRI) awarded a $993,446 Project Grant (CFDA 93.172 - Human Genome Research) to the Sloan-Kettering Institute for Cancer Research in New York. The grant, awarded on May 1, 2025, will fund the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical cooperative programs of genes and genomic elements. Key...

This federal Project Grant award for $1,312,212 from the National Institute of Environmental Health Sciences (NIEHS) under the Medical Library Assistance (CFDA 93.879) program will support research to develop an advanced DNA language model. The primary goal is to use natural language processing techniques to better understand the role and functionality of DNA sequences, especially non-coding regions, which could lead to advancements in areas like genetic testing and personalized medicine. The 3-year project, set to begin on September 1, 2024, will explore methods for modeling DNA as a form of biological language, enabling multi-task learning to uncover fundamental mechanisms driving DNA regulation. This innovative framework has the potential to significantly expand the scope of genetic variants that can be reported in clinical testing, enhancing the identification of genetic contributions to health and disease.

Generated 7/1/25, 4:52 AM